Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
25 results
D3.166 - Attention-deficit/hyperactivity disorder (ADHD) in asthmatic children
D3.168 - Clinical Department of Allergy Center in Linköping
D3.169 - Paediatric Severe Acute Respiratory Infections in Malta: A Three-Year Review
D3.171 - Validation of the Kazakh Version of the Asthma Quality of Life Questionnaire (AQLQ) for Clinical Use in Adult Patients with Asthma
D3.173 - Switching from Dupilumab to Tezepelumab in a Child with Severe Asthma and Atopic Dermatitis: Clinical Considerations and Therapeutic Implications
D3.174 - Short-term tolerance of omlyclo, the omalizumab biosimilar
D3.175 - Algorithm for Biologics Selection in Severe Asthma
D3.178 - Assessment of blood rheological properties in children with bronchial asthma
D3.179 - Longitudinal breath profiling of exhaled volatile organic compounds differentiates viral-induced asthma exacerbation from clinical control
D1.496 - Variation in platelet-activating factor levels among patients with chronic spontaneous urticaria
D1.507 - Biomarkers of T2-airway inflammation in patients with asthma and COPD overlap
D1.495 - Noninvasive Monitoring of Cutaneous Molecular Changes During Improvement of Infantile Atopic Dermatitis: Application of Skin Surface Lipid RNA (SSL-RNA) Analysis
D1.497 - An integrated multiomic insight to nonsteroidal anti-inflammatory drug-induced acute urticaria/angioedema
D1.498 - Altered B Cell Dynamics in Childhood-Onset Systemic Lupus Erythematosus: Insights from Disease States and Rituximab Treatment
D1.499 - A clinically validated kinin biomarker assay to differentiate bradykinin-mediated from mast cell-mediated angioedema
D1.503 - Immunoglobulin Abnormalities in Cronkhite-Canada Syndrome: A Focus on IgE and IgG4
D1.504 - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: Clinical Characteristics and Outcomes in a series of pediatric cases
D1.505 - Impact of patient factors on the stability of anti-IgE treatment response in chronic spontaneous urticaria
D1.506 - Mast cell activation and type 2 inflammation in heart failure with preserved ejection fraction: a pilot cross-sectional study
D1.508 - Assessment of automated serum sIgG testing for key bacterial pathogens in Cystic Fibrosis
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download